Jordan, Michael B.

An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder

Jordan, M. B., Hildeman, D., Kappler, J., & Marrack, P. (2004) · Blood

Autoimmune and Inflammatory Disorders ResearchImmunodeficiency and Autoimmune Disorders

Cited by 712

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

Locatelli, F., Jordan, M. B., Allen, C., Cesaro, S., Rizzari, C., Rao, A., Degar, B., Garrington, T. P., Sevilla, J., Putti, M.-C., et al. (2020) · New England Journal of Medicine

Autoimmune and Inflammatory Disorders ResearchImmunodeficiency and Autoimmune Disorders

Cited by 534

Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH

Zhang, K., Jordan, M. B., Marsh, R. A., Johnson, J. A., Kissell, D., Meller, J., Villanueva, J., Risma, K. A., Wei, Q., Klein, P. S., et al. (2011) · Blood

Autoimmune and Inflammatory Disorders ResearchImmunodeficiency and Autoimmune Disorders

Cited by 428

Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab

Marsh, R. A., Allen, C. E., McClain, K. L., Weinstein, J. L., Kanter, J., Skiles, J., Lee, N. D., Khan, S. P., Lawrence, J., Mo, J. Q., et al. (2013) · Pediatric Blood & Cancer

Autoimmune and Inflammatory Disorders ResearchKawasaki Disease and Coronary Complications

Cited by 310

Hemophagocytosis causes a consumptive anemia of inflammation

Zoller, E. E., Lykens, J. E., Terrell, C. E., Aliberti, J., Filipovich, A. H., Henson, P. M., & Jordan, M. B. (2011) · Journal of Experimental Medicine

Autoimmune and Inflammatory Disorders ResearchIron Metabolism and Disorders

Cited by 228

Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis

Johnson, T. S., Terrell, C. E., Millen, S. H., Katz, J. D., Hildeman, D. A., & Jordan, M. B. (2014) · The Journal of Immunology

Autoimmune and Inflammatory Disorders ResearchImmunodeficiency and Autoimmune Disorders

Cited by 203

Perforin is a critical physiologic regulator of T-cell activation

Lykens, J. E., Terrell, C. E., Zoller, E. E., Risma, K., & Jordan, M. B. (2011) · Blood

Autoimmune and Inflammatory Disorders ResearchT-cell and B-cell Immunology

Cited by 150

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease

Fajgenbaum, D. C., Langan, R.-A., Japp, A. S., Partridge, H. L., Pierson, S. K., Singh, A., Arenas, D. J., Ruth, J. R., Nabel, C. S., Stone, K., et al. (2019) · Journal of Clinical Investigation

IgG4-Related and Inflammatory DiseasesViral-associated cancers and disorders

Cited by 147